FindTrial
Sign In

The interaction relationship between ketamine and remifentanil in pediatric patients

The interaction relationship between ketamine and remifentanil in pediatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097368
Enrollment
Unknown
Registered
2025-02-18
Start date
2024-06-05
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Young age group:Ketamine
Elderly group:Ketamine

Sponsors

Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Children undergoing elective general anesthesia surgery, ASA grade I or II., age 1~6 years, gender is not limited, body mass index is 13~20kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Patients with upper respiratory tract infection in the past 2 weeks; 2. Anemia, malnutrition, abnormal liver and kidney function; 3. Severe cardiovascular disease; 4. Persons with intellectual disabilities; 5. Have neuropsychiatric diseases; 6. History of allergy to anesthetic drugs; 7. History of taking sedative-hypnotic drugs.

Design outcomes

Primary

MeasureTime frame
ED95;—

Secondary

MeasureTime frame
Mean Arterial Pressure, MAP;Heart Rate;Adverse reactions during medication;—

Countries

China

Contacts

Public ContactJi Leting

Third Affiliated Hospital of Zhengzhou University

jlt0001@126.com+86 185 3800 6729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026